QR678 names industry veteran and med-tech leader Sridhar Ranganathan to advisory board

Sridhar Ranganathan is the former Managing Director of Allergan

by e4m Staff
Published: Sep 25, 2024 1:06 PM | 2 min read

QR678 has appointed Sridhar Ranganathan to its Board of Advisors.

Sridhar Ranganathan is the former Managing Director of Allergan.

Indrajit Dutta, Vice President, QR678, said, “We are thrilled to welcome Sridhar to the QR678® Board of Advisors. His exceptional background in medtech and pharmaceuticals, coupled with his strategic vision and leadership, will be invaluable as we continue to advance our innovative hair regrowth therapy. Sridhar’s deep understanding of market dynamics, combined with his ability to steer transformative initiatives, will undoubtedly propel QR678® to new heights in both domestic and international markets."

Adding further, Sridhar Ranganathan said, “The way QR678® has progressed and its penetration in the hair growth segment is nothing short of phenomenal. What excites me about QR678® is not just its significant impact in India but its potential to revolutionize hair regrowth therapy globally. The rigorous research and academic intensity backing QR678®, along with its established place in the market, make it an extraordinary journey to be part of. I look forward to collaborating with the team to support QR678®’s strategic goals and further its mission of revolutionizing hair regrowth therapy.”

He also shared his thoughts for doctors and aesthetic practitioners: “For practitioners, understanding QR678® in detail and how it can be integrated into their practice is crucial. Whether used as a monotherapy or in combination with other treatments, QR678® offers a robust solution for managing patients with androgenetic alopecia. I believe it can become an essential tool in every practitioner’s arsenal.”